Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium [Phase 2]
This updates the completion of a Phase 2 trial of sunitinib in patients with progressive metastatic urothelial cancer (transitional cell car…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]
Phase 1 safety study of an antisense product in multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes [NA]
A completed clinical trial evaluated SVV-guided fluid therapy during bladder cancer surgery. It examined whether this approach reduces intra…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Comparison of White Light, PDD and NBI in Detection of Flat Dysplasia and CIS at TURB - a Study of Trimodality
A study comparing White Light cystoscopy, fluorescence PDD, and Narrow Band Imaging for detecting flat dysplasia and carcinoma in situ durin…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma [Phase 2]
Amrubicin was tested as a second-line therapy in advanced/metastatic refractory urothelial carcinoma in a Phase 2 trial; the study was termi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
A completed study investigating whether genetic factors influence recurrence and progression in non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Use of Multiphoton Microscopy in the Diagnosis of Cancer [Phase 1]
Phase 1 trial evaluating multiphoton microscopy for diagnosing bladder and prostate cancer, completed.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy [Phase 2, Phase 3]
A completed Phase 2/3 randomized trial in advanced bladder cancer comparing first-line gemcitabine with versus without vinflunine in patient…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer [NA]
This is a completed pilot trial evaluating Lipiodol for demarcating bladder tumors in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer [Phase 1]
Phase I trial evaluating mitomycin C combined with BCG for bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer [Phase 2]
Phase 2 trial of MVAC chemotherapy followed by Gemcitabine plus Cisplatin in locally advanced or metastatic bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer [Phase 2]
Phase 2 trial evaluating gefitinib (Iressa) in combination with docetaxel (Taxotere) for metastatic urothelial cancer (bladder cancer) was t…
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating sorafenib in advanced or metastatic urothelial cancers of the urinary tract (including bladder, renal pelvis, and u…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluated prostate capsule-sparing cystectomy and nerve-sparing radical cystoprostatectomy in men with bladder canc…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial tested the combination of gemcitabine, cisplatin, and radiation therapy in patients with stage II or stage III bladder can…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Tipifarnib in Treating Patients With Recurrent Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating tipifarnib for recurrent bladder cancer has completed (status: COMPLETED) according to the sponsor Unive…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block [NA]
Completed clinical trial comparing nerve-stimulating versus interfascial injection approaches for sono-guided obturator nerve block; results…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating bortezomib in patients with advanced or metastatic transitio…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS [EARLY_Phase 1]
An early-phase 1 trial evaluating bladder cancer screening in patients with diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
A completed clinical trial evaluated granulocyte-colony stimulating factor (G-CSF) for prevention of chemotherapy-induced febrile neutropeni…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy [EARLY_Phase 1]
An early Phase 1 neoadjuvant trial evaluating rapamycin in invasive bladder cancer stage II patients undergoing radical cystectomy has compl…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) [Phase 2, Phase 3]
The document reports the completion status of a Phase 2/3 clinical trial evaluating intravesical valrubicin (AD 32) for carcinoma in situ of…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
This clinical trial update describes a prospective registry to assess the effectiveness and local tolerability of intravesical valrubicin in…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer [Phase 2]
Phase 2 study of panitumumab in combination with gemcitabine and cisplatin for advanced urothelial (bladder) cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium [Phase 1]
A Phase 1 trial from MD Anderson Cancer Center evaluated short-term low-dose interferon alfa in patients with urothelial cancers (bladder an…